RoboCT
程天科技
RoboCT (程天科技) is a Chinese exoskeleton company that BlueRun Ventures has identified as a domestic leader in the field . The firm developed its own closed-loop technology stack to achieve what BlueRun described as disruptive cost-structure innovation at the clinical-product level . BlueRun Ventures was the sole investor in RoboCT's Series A round and also participated in its Series A+ , with partner Cao Wei among those who led the investment . The company has since expanded from medical-grade exoskeletons toward the consumer market, placing it in competition with newer entrants like Hypershell Tech . In early 2026, RoboCT closed another 100-million-yuan B+ round to accelerate exoskeleton consumerization .
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Leads Round as SiClink Focuses on Visual Reconstruction, Exploring New Frontiers in Brain-Computer Interfaces | BlueRun Portfolio
Bidirectional interaction is the critical turning point that transforms brain-computer interfaces from "functional compensation tools" into "information interfaces."
BlueRun Ventures Portfolio Company Puyu Technology Closes Hundreds of Millions of RMB Financing to Accelerate Nanoimprint Lithography Equipment Commercialization | BlueRun Family
Opening a New Front for China's Semiconductor Breakthrough
BlueRun Ventures Portfolio Company Tian Cheng Technology Closes Another 100-Million-Yuan B+ Round to Accelerate the "Human-Machine Fusion" Era of Exoskeleton Consumerization | BlueRun Family
Making the leap from "rehabilitation tool" to "enhancement partner."
Hypershell Closes Two Rounds Totaling $70 Million in Funding
Toward a Future Where Everyone Is "Iron Man"?
They Talk, We Create | Quarterly
The evening breeze of a summer night is the sound of the future rushing in.
Welcome to Register: 2025 World Robot Conference Project Roadshow and Investment-Matching Session | BlueRun Ventures × Shoucheng Capital
Face to Face with a Robot
Planting Spring in the Wind | Quarterly
On the Move
Tian Cheng Technology Closes Nearly 100 Million RMB Series B Round to Accelerate Global Expansion of Embodied Intelligence Exoskeletons | BlueRun Family
Technology should serve everyone.
Birds Fly Over the Harsh Winter | Monthly
Spring mountains within sight, the future there to climb.
BlueRun Ventures and Ant Group Are Looking for the Most Hardcore Deep-Tech Founders — Is That You? | Registration Closing Soon
From barely a peep to booming — come aboard!
SRO! How Embodied Intelligence Tech Is Going Industrial, From the BlueRun Ventures Forum at the World Robot Conference
From the Lab to the Real World
9 Days to Go! World Robot Conference × BlueRun Ventures | General-Purpose Robotics and Embodied AI Frontier Technology Industrialization Forum Set to Debut
Embracing the Era of General-Purpose Robots Together
Breaking Through Your Mental Block in an Olympic Year | BlueRun Ventures Bi-Monthly Report
OUVRONS GRAND LES JEUX This text is already in French, not Chinese. It translates to English as: **LET THE GAMES BEGIN** Or more literally: "Let's open the games wide" / "Let the games open grandly" (This is the official slogan/tagline for the Paris 2024 Olympic and Paralympic Games.)
Early Summer, Time to Surf to Your Heart's Content! | BlueRun Ventures Bi-Monthly Report
The thrill of surfing freely under a blazing sun.
BlueRun Ventures Portfolio Companies Named to 2024 Future Healthcare 100 List
Continuously searching for next-generation biotech companies that align with industry logic
The Best Time of Spring | February & March Bi-Monthly Report
Though it goes unnoticed, new life is already quietly taking root.
The Future Looks Very Different | December & January Bimonthly Report
Witnessing BlueRun Ventures' "Defining Moment"
BlueRun Ventures Quarterly Investment & Financing Overview | 2023 Q4
Sector distribution spans artificial intelligence, enterprise services, hard tech, and biotech, among others.
Looking at the Other Side of the Coin | October & November Report
Grateful for what life has given
No Matter How Far, We Can Get There | August & September Bi-Monthly Report
Go Far Away
Tian Cheng Technology Secures Investment from Pappas Capital, Focusing on Exoskeleton Robotics for Tech-Enabled Elderly Care | BlueRun Ventures
Ranked first globally in both the number of rehabilitation exoskeletons deployed and in active use
Surging Waves, Endless Ascent | June Report
Go all in, or don't join at all.
The Road to AGI | Supercharged by Large Models, Robotics Is Entering a New Era
What unresolved problems will it solve for intelligent systems?
Multiple BlueRun Ventures portfolio companies named to 2023 Future Healthcare 100 list
Standing by founders from 0 to 1 to redefine the future.
Jui Chan, BlueRun Ventures: Riding the Waves — Don't Waste a Crisis | BlueRun Perspectives
Adaptability is the eternal question for investors.
You Can't Predict. You Can Prepare | April Report
Riding the Unpredictable Wave
Official Announcement: BlueRun Ventures Has Hired Virtual Knowledge Workers | March Report
Midjourney designers, your hard work is appreciated.
Let the Brain Wander | BlueRun Ventures February Report
Looking Forward Amid the Hustle
Be the change we want to see | BlueRun Ventures December Report
Memorable Moments from December
BlueRun Ventures' Cao Wei Named to FOFWEEKLY's "Top 100 People in Equity Investment 2022"
Spotting what founders actually need earlier and more precisely at the 0-to-1 stage
Those Who Remain Unchanged by Today Will Change Tomorrow | BlueRun Ventures October & November Newsletter
What has BlueRun Ventures been up to these past two months?
BlueRun Ventures Salon Series Now Open for Registration | Robots: Breaking Through Cycles and the Road Ahead
December 1, 19:00–21:00: A Discussion on Breaking Through and the Future of Robotics Entrepreneurship
BlueRun Ventures' Cao Wei: Tesla's Humanoid Optimus Is Nothing New — The Robotics Sector's Reach Is Far Beyond What Anyone Imagines
We will ultimately advance human evolution through robotics.
Galloping Through August | Living Up to the Summer, Chasing What We Love
Every step counts.
BlueRun Ventures June Report | Hope Is a Sweet Waiting
Looking out from a bountiful June
"Exoskeleton Robots: Iron Man, Black Panther, or Venom?" — BlueRun Ventures
Cracking the Exoskeleton Robot Supply Chain: How ChengTian Technology Plans to Break Through Commercialization in Its New Decade
BlueRun Ventures and Portfolio Companies Win Nearly 60 Awards from 36Kr, ChinaVenture, Rongzhong, TMTpost, VBData, and More | H1 Highlights
Deep commitment to early-stage investing, with a belief in technology as a driver of transformation.
BlueRun Ventures May Newsletter | Remember Why You Started
What's New at BlueRun Ventures in May
BlueRun Ventures Closes New RMB 5.5 Billion Dual-Currency Fund
Focused on early-stage technology, unwavering in our support for founders who dare to lead.
